共 50 条
- [24] Eflapegrastim (Rolvedon) for Prevention of Chemotherapy-Induced Febrile Neutropenia MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1677): : 83 - 84
- [25] A new prognostic model for chemotherapy-induced febrile neutropenia International Journal of Clinical Oncology, 2016, 21 : 46 - 52